Third, the tumour phenotype of mice with genetic deletion of Tie2 in pericytes warrants some careful reconsideration of the concepts of therapeutic angiopoietin targeting to interfere with tumour angiogenesis and for the future design of anti-angiogenic combination therapies. This evidence concerns the gene TEK and neoplasm.